Retatrutide GLP3 20mg
(GLP‑1/GIP/Glucagon)

Premium Grade | UK Supply

(Nonatriacontapeptide–39 Amino Acids)

Brief Summery

Retatrutide is a premium grade research peptide studied for its activity across metabolic signalling pathways, particularly receptor systems linked to glucagon, GLP-1, and GIP research models. In laboratory and preclinical settings, it is commonly examined for multi-receptor pathway interaction, energy balance signalling, adipose tissue related mechanisms, glucose regulation markers, and comparative metabolic assay design. Its structure and receptor profile make it useful for researchers exploring how combined incretin and glucagon pathway activity may influence cellular signalling responses. Retatrutide is supplied for scientific research purposes only and is not intended for human consumption, clinical use, or medical application.

Product Overview

Retatrutide is a long acting peptide extensively researched for its role in multi receptor metabolic signalling and endocrine pathway modulation. It is scientifically distinguished by its ability to interact with multiple peptide hormone receptors involved in energy balance, metabolic regulation, and nutrient utilisation signalling. Due to its advanced molecular design and broad pathway engagement, Retatrutide has become one of the most significant peptides in modern metabolic and endocrine research. In laboratory and research environments, Retatrutide is utilised to investigate complex metabolic signalling networks, receptor crosstalk, and integrated hormonal pathway regulation. Unlike single pathway peptides, Retatrutide enables the study of coordinated receptor activation and downstream signalling convergence, making it a powerful research tool for advanced metabolic modelling and systems level endocrine investigation. Retatrutide’s strong scientific interest, combined with its innovative receptor profile and stability, positions it as a flagship peptide for cutting edge research into metabolic control mechanisms and energy regulation pathways. 

Scientific Background

Retatrutide is classified as a multi-agonist peptide, designed to activate several key receptors involved in metabolic and energy homeostasis signalling. Research demonstrates that Retatrutide engages glucagon like peptide 1 (GLP-1), glucose dependent insulinotropic polypeptide (GIP), and glucagon receptors, allowing researchers to study simultaneous modulation of complementary metabolic pathways within a single molecular framework. At the molecular level, receptor activation by Retatrutide initiates intracellular signalling cascades involving cyclic AMP, protein kinase pathways, and transcriptional regulators that collectively influence glucose metabolism, lipid utilisation, appetite related signalling, and energy expenditure pathways. This tri-agonist profile enables unprecedented investigation into receptor synergy, pathway amplification, and metabolic signalling integration. The structural stability and prolonged activity of Retatrutide allow for sustained receptor engagement, making it particularly valuable for long duration experimental models examining adaptive metabolic responses, endocrine feedback mechanisms, and signalling plasticity across interconnected metabolic systems. 

Research Applications

Retatrutide is extensively researched in metabolic science, endocrinology, and molecular biology, particularly in studies focused on obesity related metabolic pathways, glucose regulation signalling, and systemic energy balance models. Researchers utilise Retatrutide to explore how multi receptor activation influences metabolic efficiency, substrate utilisation, and endocrine coordination in controlled laboratory environments. In advanced metabolic research, Retatrutide is employed to investigate receptor crosstalk between GLP-1, GIP, and glucagon signalling systems, providing insight into synergistic and compensatory mechanisms that govern energy regulation. These studies support deeper understanding of complex metabolic network behaviour beyond single hormone models. Additionally, Retatrutide is used in high level research examining long term metabolic adaptation, signalling durability, and endocrine system responsiveness. Its unique tri-agonist design and extensive scientific relevance making Retatrutide one of the most important and sought after peptides in contemporary metabolic and endocrine research.
(Read More About Retatrutide In Our Article)

Technical Specifications

• Contents: 20mg Retatrutide
• Form: Lyophilized powder
• Purity: >99% (HPLC Verified)
• Molecular Formula: C₂₂₁H₃₄₂N₄₆O₆₈
• Sequence: Tyr-{Aib}-Gln-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Ile-{α-Me-Leu}-Leu-Asp-Lys-{diacid-C₂₀-γGlu-(AEEA)-Lys}-Ala-Gln-{Aib}-Ala-Phe-Ile-Glu-Tyr-Leu-Leu-Glu-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH₂
• Peptide Length: 39 Amino-Acids
• pH Range: Soluble and stable in aqueous solution adjusted to pH ~9 with NH₃·H₂O
• Storage: Store between 2°C and 8°C

Note: Reconstitute with 50% Bacteriostatic (BAC) water and 50% Acetic Acid for best results.

Related Research Compounds

Cagrilintide 10mg
Mazdutide 10mg
Tesamorelin 10mg

Disclaimer

For research purposes only, Not for human consumption.